Updated: February 20, 2026
218 people read this article
Alternatives to Trelegy If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
Can't fill your Trelegy Ellipta prescription? Learn about the best alternatives, including Breztri Aerosphere, Breo Ellipta, and Symbicort.
Can't Find Trelegy? Here Are Your Alternatives
If you depend on Trelegy Ellipta to manage your COPD or asthma and suddenly can't fill your prescription, it's understandable to feel anxious. Going without your maintenance inhaler can lead to worsening symptoms, flare-ups, and even emergency room visits.
The good news: there are several effective alternatives your doctor can prescribe. In this guide, we'll explain what Trelegy does, how it works, and walk through the best alternatives available in 2026.
Important: Never switch medications on your own. Always talk to your doctor before starting or stopping any inhaler.
What Is Trelegy Ellipta?
Trelegy Ellipta is a once-daily triple-combination inhaler made by GlaxoSmithKline. It combines three medications in one device:
- Fluticasone Furoate (ICS) — reduces inflammation in the airways
- Umeclidinium (LAMA) — relaxes the muscles around the airways by blocking certain nerve signals
- Vilanterol (LABA) — keeps the airways open by stimulating beta-2 receptors in the lungs
It's approved for maintenance treatment of COPD and asthma in adults 18 and older. The strength for COPD is 100/62.5/25 mcg, and for asthma there's also a 200/62.5/25 mcg option with a higher dose of the steroid component.
How Does Trelegy Work?
Trelegy works by attacking airway obstruction from three different angles simultaneously:
- Anti-inflammatory action: Fluticasone Furoate calms the chronic inflammation that narrows airways in COPD and asthma.
- Anticholinergic bronchodilation: Umeclidinium blocks acetylcholine at M3 receptors in the airways, preventing the muscle tightening that makes it hard to breathe.
- Beta-agonist bronchodilation: Vilanterol relaxes airway smooth muscle through a different pathway, providing additional bronchodilation on top of what Umeclidinium does.
This triple approach is why Trelegy is so effective — and why finding a true equivalent requires either another triple inhaler or a combination of two separate inhalers.
Alternatives to Trelegy Ellipta
1. Breztri Aerosphere (Budesonide / Glycopyrrolate / Formoterol Fumarate)
Breztri Aerosphere is the closest alternative to Trelegy. It's also a triple-combination inhaler containing an ICS, LAMA, and LABA — just with different active ingredients. Breztri is FDA-approved for COPD maintenance (not currently approved for asthma).
Key differences from Trelegy:
- Breztri uses a metered-dose inhaler (MDI) with a pressurized canister, while Trelegy uses a dry powder inhaler (Ellipta device)
- Breztri is dosed twice daily (two inhalations, twice a day), compared to Trelegy's once-daily dosing
- Some patients may find one device easier to use than the other
The cash price for Breztri is comparable to Trelegy, typically ranging from $550 to $650 per month. Check with your insurance to see if Breztri has different coverage or copay requirements.
2. Breo Ellipta (Fluticasone Furoate / Vilanterol) — ICS/LABA Dual Therapy
Breo Ellipta contains two of Trelegy's three ingredients — the steroid (Fluticasone Furoate) and the LABA (Vilanterol) — in the same Ellipta device. It's approved for both COPD and asthma.
Breo is a step-down option if you can't access triple therapy. It provides anti-inflammatory and bronchodilator benefits but lacks the anticholinergic (LAMA) component. Your doctor might also add a separate LAMA inhaler like Incruse Ellipta (Umeclidinium) alongside Breo to replicate the full triple therapy.
The combination of Breo Ellipta plus Incruse Ellipta essentially gives you the same three active ingredients as Trelegy — just in two separate devices instead of one.
3. Anoro Ellipta (Umeclidinium / Vilanterol) — LAMA/LABA Dual Therapy
Anoro Ellipta pairs the LAMA and LABA components without the steroid. It's FDA-approved for COPD maintenance. This may be appropriate for COPD patients whose condition is managed primarily through bronchodilation and who have a lower inflammatory burden.
If you need the anti-inflammatory component too, your doctor could add a separate ICS inhaler (like Arnuity Ellipta or Flovent) to Anoro to achieve a similar triple effect.
4. Symbicort (Budesonide / Formoterol) — ICS/LABA Dual Therapy
Symbicort is a widely prescribed ICS/LABA combination available as a metered-dose inhaler. It's approved for both COPD and asthma. A key advantage of Symbicort is that generic versions are available, which can significantly reduce cost — often $50 to $150 per month compared to Trelegy's $580+ cash price.
Like Breo, Symbicort lacks a LAMA component. Your doctor may pair it with a standalone LAMA like Spiriva (Tiotropium) to achieve triple therapy.
How to Decide Which Alternative Is Right for You
The best alternative depends on several factors:
- Your diagnosis: COPD and asthma have different treatment guidelines. Breztri is only for COPD, while Breo and Symbicort work for both.
- Inhaler technique: Some patients do better with dry powder inhalers (Ellipta) and others with pressurized MDIs. Discuss your preferences with your doctor.
- Cost and insurance: Generic Symbicort is far more affordable than brand-name triple inhalers. If cost is a major factor, a dual inhaler plus add-on may be the best approach.
- Dosing convenience: Trelegy's once-daily dosing is hard to beat. Breztri and Symbicort require twice-daily dosing. If adherence is a concern, once-daily options may be preferable.
Talk to your doctor about which alternative makes the most sense for your specific situation. You can also read more about what Trelegy is and how it's used to better understand what you'd be replacing.
Final Thoughts
Not being able to fill your Trelegy prescription is stressful, but it's not a dead end. Effective alternatives exist — from Breztri Aerosphere (another triple inhaler) to dual-inhaler combinations using Breo, Anoro, or Symbicort plus a LAMA.
The most important thing is to not go without treatment. Contact your doctor as soon as you know you can't fill your Trelegy, and they'll work with you to find the right substitute.
In the meantime, use Medfinder to check if Trelegy is available at another pharmacy near you — the solution might be simpler than you think. For more tips, see our guide on how to find Trelegy in stock near you.
Frequently Asked Questions
Breztri Aerosphere (Budesonide/Glycopyrrolate/Formoterol) is the closest alternative because it's also a triple-combination inhaler containing an ICS, LAMA, and LABA. It's FDA-approved for COPD maintenance. The main differences are that Breztri uses an MDI device and requires twice-daily dosing instead of once daily.
Yes, many patients use two inhalers to get the same triple therapy as Trelegy. For example, Breo Ellipta (ICS/LABA) plus Incruse Ellipta (LAMA) provides the same three active ingredients. Your doctor can set up a two-inhaler combination that matches your needs.
Generic Symbicort (Budesonide/Formoterol) is significantly cheaper than Trelegy, often costing $50 to $150 per month. However, it only contains an ICS and LABA — you may need to add a separate LAMA inhaler. Talk to your doctor about whether a more affordable combination could work for your condition.
No, you should never switch inhalers without consulting your doctor. While Breztri and Trelegy are both triple-combination inhalers, they contain different active ingredients, use different devices, and have different dosing schedules. Your doctor will ensure the switch is safe and appropriate for your condition.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Trelegy also looked for:
More about Trelegy
29,314 have already found their meds with Medfinder.
Start your search today.





